Scholar Rock Holding (SRRK) Property, Plant & Equipment (Net) Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.32% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.12% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -10.19% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 24.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.18% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.92% |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | -45.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.62% |
| Dec 31, 2025 | -38.25% |
| Sep 30, 2025 | -32.95% |
| Jun 30, 2025 | -31.33% |
| Mar 31, 2025 | -34.65% |
| Dec 31, 2024 | -39.98% |
| Sep 30, 2024 | -40.26% |
| Jun 30, 2024 | -40.76% |
| Mar 31, 2024 | -39.56% |
| Dec 31, 2023 | -37.70% |
| Sep 30, 2023 | -35.11% |
| Jun 30, 2023 | -31.51% |
| Mar 31, 2023 | -29.36% |
| Dec 31, 2022 | -22.79% |
| Sep 30, 2022 | -14.71% |
| Jun 30, 2022 | -7.27% |
| Mar 31, 2022 | 5.97% |
| Dec 31, 2021 | 17.77% |
| Sep 30, 2021 | 72.00% |
| Jun 30, 2021 | 155.64% |
| Mar 31, 2021 | 122.40% |
| Dec 31, 2020 | 94.70% |
| Sep 30, 2020 | 28.74% |
| Jun 30, 2020 | 6.31% |
| Mar 31, 2020 | 10.13% |
| Dec 31, 2019 | 30.75% |
| Sep 30, 2019 | 64.17% |
| Jun 30, 2019 | 87.02% |
| Dec 31, 2018 | 46.26% |